News

Oleuropein-loaded exosomes boosted antiaging gene activity and offered a novel skincare approach. A study published in July ...
Spectral flow cytometry is redefining how complex cell populations are analyzed. This guide outlines the most important considerations to run a spectral flow cytometry experiment successfully.
Circulating tumor cells (CTCs) are a reliable marker of disease progression in melanoma and can reliably be detected using flow cytometry, suggests a small study of patients with the skin disease ...
Flow cytometry panel building can be daunting, whether you’re working with a 4-color panel or a complex 30-color setup. This article explores common challenges faced by flow cytometry users, such as ...
Challenging the long-standing belief that fibroblasts produce skin collagen, researchers at Okayama University have investigated collagen formation in the ‘glass-skinned’ amphibian ...
A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor environment. The ...
Despite the dazzle of its spectral capabilities, flow cytometry is helping users focus on their research, clinical, and diagnostic applications.
Two cases of T-ALL are discussed, in which the absence of common flow cytometry immaturity markers and positive γδ receptor expression occurred.
Flow cytometry is a technique that doctors can use to perform immunophenotyping. Immunophenotyping is a process that helps doctors identify cell types based on specific markers on the cell surface.
William Telford, a Senior Associate Scientist at the NCI, shares his ten top tips for successful flow cytometry in this handy guide.
Applications of flow cytometry encompass clinical management, the design of therapeutics and vaccines, and the development of better cell therapies.
Finally, combined blood and skin fibroblasts’ network analysis identifies increased interactions between blood immune cells and skin fibroblasts, suggesting a novel role for these cells in disease ...